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The extraction of periplasmic b-lactamases from Gram-negative bacilli is a necessary preliminary step to
analytical isoelectric focusing. Previously described methods are time-consuming and require large
amounts of broth. We describe a lysozyme-based method which needs just 5 mL broth and requires less
than 24 h to perform. The method was reproducible in extracting b-lactamases from reference strains
containing known b-lactamases. We applied the method to a collection of more than 70 extended-spectrum
b-lactamase-producing isolates from a multinational study of bacteremic isolates of Klebsiella pneumoniae.
Further studies are being undertaken to assess the method’s applicability to other bacterial species.
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Since the early 1980s frequent isolates of Klebsiella pneumoniae
and other Enterobacteriaceae have been detected which har-
bour extended-spectrum b-lactamases (ESBLs) [1–3]. Initial
characterization of ESBLs may involve analytical isoelectric
focusing (aIEF). Characterization of ESBLs from clinical strains
of Gram-negative bacteria by aIEF relies on liberation of the
periplasmic enzyme from bacterial cells.
Traditional methods of extraction of ESBLs from Gram-
negative bacteria have been cumbersome and time-consuming
and have required large volumes of broth. Previously described
methods for b-lactamase extraction include sonication, passage
through a French pressure cell, repeated freeze–thaw cycles and
osmotic shock [4–6]. In general, such methods utilize expo-
nential phase or stationary phase bacterial cells grown in large
volumes (for example, 5 L) of broth [5]. Since most laboratories
are equipped with orbital shakers that can only hold 2 L flasks,
there is a limit to the number of specimens that can be processed
at any one time.
We describe a rapid method of b-lactamase extraction from
K. pneumoniae. It requires less than 24 h to perform and the
volume needed is only 5 mL broth per sample. It is a modifica-
tion of a previously described method for the analysis of
recombinant proteins in Escherichia coli [7]. We have found it
reproducible and applicable to the analysis of large numbers of
strains of K. pneumoniae.
A prospective study of K. pneumoniae bacteremia was per-
formed in 12 hospitals in the United States, Belgium, Turkey,
Taiwan, Australia, South Africa and Argentina [8]. Blood
culture isolates from each patient were frozen at 80 8C, and
at the conclusion of the study were sent to a central study
laboratory. There, the identity of each isolate was confirmed as
K. pneumoniae using standard methods [9]. ESBL production
was phenotypically determined at the central study laboratory
by broth dilution using National Committee for Clinical
Laboratory Standards (NCCLS) performance standards that
were current as of January 2000 [10].
In order to extract periplasmic b-lactamases, an isolated
colony of K. pneumoniae growing on agar plates containing
ampicillin 100 mg/L was first inoculated into a tube containing
5 mL of Luria-Bertani (LB) broth and 100 mg/L ampicillin. We
grew bacterial cultures overnight at 37 8C in an orbital shaker
run at approximately 250 r.p.m. Stationary-phase cells were
centrifuged at 1930 g at 4 8C for 7 min. The supernatant was
discarded and the pellet was resuspended in 500 mL 50 mM Tris–
HCl (pH 7.4) and transferred to a 1.5 mL Eppendorf tube. A
fresh solution of lysozyme (Sigma Pharmaceuticals, St. Louis,
MO) was prepared by dissolving 40 mg lysozyme in 1 mL Tris
buffer (pH 7.4). Two microlitres of this 40 mg/mL lysozyme
solution was then added and the tube was gently rotated at room
temperature for 30 min. Ten microlitres 0.5 M ethylenediamine
tetraacetic acid (EDTA, pH 8.5) was then added to a final
concentration of 1 mM. After further gentle rotation for
10 min at ambient temperature, the tube was centrifuged for
6 min at 14 000 r.p.m. We tested for b-lactamase activity in the
supernatant, using the chromogenic substrate, nitrocefin (con-
centration 100 mM; Becton Dickinson, Cockeysville, MD).
Nitrocefin undergoes a color change from yellow to red as
the cephalosporin is hydrolysed by the b-lactamase.
We performed initial characterization of the b-lactamases in
these clinical isolates by aIEF as previously described [11]. Ten
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microlitres of the crude enzyme extract was loaded onto a
precast gel (Ampholine PAGplate, Pharmacia, Piscataway, NJ).
We used gels with a pH range of 3.5–9.5 as part of the initial
screen. Isolates with previously characterized b-lactamases were
used as controls (Table 1). In addition, RTEM-1 enzyme from
E. coli 205 (Sigma Pharmaceuticals) was loaded onto a gel as
control b-lactamase (pI 5.4).
Test isolates with b-lactamases in the range of known TEM
and SHV derivatives were further characterized with a second
precast gel with pH ranges 4.0–6.5 or 5.5–8.5, respectively, used
according to the recommendations of the manufacturer
(Ampholine PAGplate, Pharmacia). Running conditions were
2000 V, 30 mA and a constant power of 8 W. Isoelectric focusing
was completed usually within 1.5–2 h. Pre-stained markers
(Pharmacia, Piscataway, NJ) with a range of isoelectric points
(pI) of 4.0–9.1 were used to monitor progress by isoelectric
focusing.
Overlaying the gel with nitrocefin-soaked filter paper
detected b-lactamase activity. The b-lactamase enzymes appear-
ed as red bands against a yellow background. Their pI were
determined by comparing the position of their bands with that
of the previously characterized controls listed above. After
detection of bands, gels were rapidly frozen in 80 8C Revco
freezer (Fisher Scientific, Pittsburgh, PA, USA) for future
analysis and comparison. We found that rapid freezing of gels
preserved the location of b-lactamase bands and prevented
unwanted smearing.
Using this technique, we successfully and reproducibly
extracted b-lactamases from each of the 10 reference isolates
described above. In each reference isolate the positive reactions
with nitrocefin were easily visible to the naked eye. The pIs of
the two groups of reference isolates consistently correlated with
their previously described pIs and that of the commercially
available TEM-1 enzyme. The b-lactamases remained detect-
able even 2 months after their extraction.
Four hundred and fifty-five episodes of K. pneumoniae bac-
teremia occurred in 440 patients during the study period. Of
these episodes, 18.7% (85/455) were due to strains presumed to
harbor ESBLs on the basis of the phenotypic confirmatory tests
of the NCCLS [10]. We successfully extracted b-lactamases
from each of the isolates presumed to harbour ESBLs on the
basis of the phenotypic confirmatory test. Isoelectric points
were determined for each isolate. These will be described
elsewhere. More than one b-lactamase was demonstrated in
the majority of strains.
The aIEF technique is widely used as the initial step in charac-
terization of b-lactamases. Knowledge of the pI of an enzyme
can allow presumptive differentiation of Amp C, TEM and
SHV type b-lactamase enzymes. In addition, if the pI of a test
b-lactamase is different from known isoelectric points, it allows
an investigator to assume that a novel enzyme may be present.
Herein, we describe a method that is rapid and reproducible. It
uses only 5 mL of broth, allowing multiple organisms to be
analysed at the same time, and is easily performed. We devised
this rapid method as a means of analysing large numbers of
isolates emanating from a multinational study of K. pneumoniae
bacteremia [8]. Processing large numbers of specimens using
standard methods was impractical. Use of 5 mL aliquots allowed
multiple b-lactamase extractions to be performed at any
one time. The rapid freezing of gels at 80 8C permitted us
to re-examine patterns and to compare gels.
We have noted that in some isolates large amounts of b-
lactamase were extracted. This led to difficulty in determination
of the precise pI of the b-lactamase since multiple bands were
identified on nitrocefin-stained gels. We remedied this by
carefully studying the rapidity of the nitrocefin color change
(excessive b-lactamase extraction is manifest by an instantaneous
color change). If color change occurs before 3–5 s have elapsed
or if satellite bands are apparent after the gel has been examined,
diluting the supernatant 1:10 or 1:100 with potassium phos-
phate buffer or Tris buffer dilutes the extracted b-lactamase
sufficiently to allow for a more accurate determination of the pI.
It is not clear why multiple bands at or around the pI appear
when the concentration of enzyme is very high. Medeiros et al.
described the phenomenon of ‘satellite bands’ (small bands
appearing in proximity to a major band) [11]. Its significance
is still not clear.
In summary, we describe a rapid and convenient method for
the extraction of b-lactamases from K. pneumoniae. This has
simplified characterization of extended spectrum b-lactamases
from this species. We have recently applied the method to
characterization of a K. pneumoniae isolate with resistance to
ceftazidime and piperacillin/tazobactam (this isolate did not
possess an extended-spectrum b-lactamase, but had high-level
expression of chromosomally encoded SHV-1 plus an outer
membrane protein change) [12]. This method is being tested
with other bacterial genera to investigate its application in other
Table1 Reference strains used to evaluate the rapid method of b-lactamase
extraction
Organism b-Lactamase pI
K. pneumoniae 5934 TEM-12 5.25
E. colia TEM-12 5.25
K. pneumoniae K2 TEM-10 5.6
E. colia TEM-2 5.6
E. coliJ53^5758 TEM-26 5.6
E. coli PCWR155 TEM-6 5.9
K. oxytocaa K1 6.5
E. coliDH10B SHV-1 7.6
E. cloacaea P99 8.2
E. colia ACT-1 9.0
aThese isolates were kindly provided by Dr Patricia Bradford (Wyeth-Ayerst
Research, Pearl River, NY). The remaining isolates were from the authors’
own collection of isolates.
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settings. We are uncertain if this method can be applied to the
analysis of metallo-b-lactamases given that these enzymes do
not uniformly hydrolyse nitrocefin well.
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